Novick W J
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S346-53. doi: 10.1093/clinids/4.supplement_2.s346.
Cefotaxime is a third-generation cephalosporin with a broad spectrum of activity. Concentrations of cefotaxime in serum and urine are sufficient for clinical efficacy. This report reviews the available data on the penetration of cefotaxime into other body fluids and tissues. Therapeutic doses of cefotaxime result in significant levels in bile (20 micrograms/ml), in cerebrospinal fluid of patients with meningitis (5-10 micrograms/ml), in pleural fluid (2-7 micrograms/ml), and in otitis media exudate (2-10 micrograms/ml). Lower levels of cefotaxime are obtained in uninflamed aqueous humor (1 microgram/ml), in breast milk (0.1-0.5 microgram/ml), and in cerebrospinal fluid of patients without meningitis (0.2 microgram/ml). Cefotaxime levels in tissues are generally well within the range required for clinical efficacy--i.e., 2-5 micrograms/g, with some higher levels reported in testis, prostate, ureter, skin, and gallbladder wall. Drug levels of less than 2 micrograms/g have been reported in fat, muscle, and uterus. All body fluids and tissues, including bone and skin, are penetrated easily by therapeutic doses of cefotaxime.
头孢噻肟是一种具有广泛抗菌活性的第三代头孢菌素。血清和尿液中的头孢噻肟浓度足以产生临床疗效。本报告回顾了有关头孢噻肟在其他体液和组织中渗透情况的现有数据。治疗剂量的头孢噻肟在胆汁(20微克/毫升)、脑膜炎患者的脑脊液(5 - 10微克/毫升)、胸腔积液(2 - 7微克/毫升)和中耳炎渗出液(2 - 10微克/毫升)中可达到显著水平。在未发炎的房水(1微克/毫升)、母乳(0.1 - 0.5微克/毫升)和无脑膜炎患者的脑脊液(0.2微克/毫升)中,头孢噻肟的水平较低。组织中的头孢噻肟水平通常在临床疗效所需范围内——即2 - 5微克/克,在睾丸、前列腺、输尿管、皮肤和胆囊壁中报告有一些较高水平。在脂肪、肌肉和子宫中报告的药物水平低于2微克/克。治疗剂量的头孢噻肟可轻易穿透所有体液和组织,包括骨骼和皮肤。